Agilent Technologies (A) EBT (2010 - 2026)

Agilent Technologies (A) has reported EBT for 17 consecutive years, with $444.0 million the latest figure, recorded in Q3 2026.

• On a quarterly basis, EBT rose 21.31% year-over-year to $444.0 million in Q3 2026; TTM through Jul 2026 was $1.7 billion, a 18.94% increase from a year earlier, with the FY2025 full-year figure at $1.4 billion, down 5.65% from the prior year.
• EBT was $444.0 million for Q3 2026 at Agilent Technologies, up from $408.0 million in the prior quarter.
• Over five years, EBT peaked at $455.0 million in Q4 2022 and troughed at $132.0 million in Q3 2023.
• A 5-year average of $369.2 million and a median of $377.0 million in 2023 frame the typical range for EBT.
• Across the five-year window, EBT sank 66.75% in 2023 and soared 159.85% in 2024, its largest moves.
• Over 5 years, EBT stood at $455.0 million in 2022, then retreated by 7.69% to $420.0 million in 2023, then decreased by 4.52% to $401.0 million in 2024, then grew by 10.22% to $442.0 million in 2025, then advanced by 0.45% to $444.0 million in 2026.
• The last three EBT figures came in at $444.0 million (Q3 2026), $408.0 million (Q2 2026), and $364.0 million (Q1 2026), per Business Quant data.